XML 175 R156.htm IDEA: XBRL DOCUMENT v3.10.0.1
Guarantor Condensed Consolidating Financial Information - Condensed Consolidating Statements of Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Condensed Income Statements, Captions [Line Items]                      
Net sales $ 1,464 $ 1,628 $ 1,816 $ 1,730 $ 1,575 $ 1,584 $ 1,588 $ 1,437 $ 6,638 $ 6,183 $ 5,400
Cost of goods sold 1,064 1,151 1,259 1,193 1,090 1,119 1,150 1,081 4,667 4,438 4,297
Gross profit                 1,971 1,745 1,103
Selling, general, and administrative expense                 657 626 946
Research and development expense                 82 81 81
Restructuring, asset-related, and other charges                 49 57 170
Total other operating expenses                 788 764 1,197
Equity in earnings of affiliates                 43 33 29
Equity in earnings of subsidiaries                 0 0 0
Interest (expense) income, net                 (195) (214) (219)
(Loss) gain on extinguishment of debt                 (38) (1) 6
Intercompany interest income (expense), net                 0 0 0
Other income (expense), net                 162 113 267
Income (loss) before income taxes 182 269 323 381 264 250 225 173 1,155 912 (11)
(Benefit from) provision for income taxes                 159 165 (18)
Net income (loss) 142 275 282 297 228 207 161 151 996 747 7
Less: Net income attributable to non-controlling interests                 1 1 0
Net income (loss) attributable to Chemours $ 142 $ 275 $ 281 $ 297 $ 228 $ 207 $ 161 $ 150 995 746 7
Comprehensive (loss) income attributable to Chemours                 873 881 (34)
Eliminations and Adjustments [Member]                      
Condensed Income Statements, Captions [Line Items]                      
Net sales                 (1,820) (1,734) (1,571)
Cost of goods sold                 (1,825) (1,691) (1,543)
Gross profit                 5 (43) (28)
Selling, general, and administrative expense                 (24) (38) (20)
Research and development expense                 0 0 0
Restructuring, asset-related, and other charges                 0 0 0
Total other operating expenses                 (24) (38) (20)
Equity in earnings of affiliates                 0 0 0
Equity in earnings of subsidiaries                 (1,157) (849) (100)
Interest (expense) income, net                 0 0 0
(Loss) gain on extinguishment of debt                 0 0 0
Intercompany interest income (expense), net                 0 0 0
Other income (expense), net                 (22) (34) (20)
Income (loss) before income taxes                 (1,150) (888) (128)
(Benefit from) provision for income taxes                 0 (4) (7)
Net income (loss)                 (1,150) (884) (121)
Less: Net income attributable to non-controlling interests                 0 0 0
Net income (loss) attributable to Chemours                 (1,150) (884) (121)
Comprehensive (loss) income attributable to Chemours                 (1,012) (1,081) (66)
Parent Issuer [Member] | Reportable Legal Entities [Member]                      
Condensed Income Statements, Captions [Line Items]                      
Net sales                 0 0 0
Cost of goods sold                 0 0 0
Gross profit                 0 0 0
Selling, general, and administrative expense                 33 36 21
Research and development expense                 0 0 0
Restructuring, asset-related, and other charges                 0 0 0
Total other operating expenses                 33 36 21
Equity in earnings of affiliates                 0 0 0
Equity in earnings of subsidiaries                 1,155 849 100
Interest (expense) income, net                 (210) (220) (217)
(Loss) gain on extinguishment of debt                 (38) (1) 6
Intercompany interest income (expense), net                 47 64 60
Other income (expense), net                 25 29 20
Income (loss) before income taxes                 946 685 (52)
(Benefit from) provision for income taxes                 (50) (62) (59)
Net income (loss)                 996 747 7
Less: Net income attributable to non-controlling interests                 0 0 0
Net income (loss) attributable to Chemours                 996 747 7
Comprehensive (loss) income attributable to Chemours                 873 881 (34)
Guarantor Subsidiaries [Member] | Reportable Legal Entities [Member]                      
Condensed Income Statements, Captions [Line Items]                      
Net sales                 3,974 3,887 3,749
Cost of goods sold                 3,112 3,084 3,218
Gross profit                 862 803 531
Selling, general, and administrative expense                 485 449 794
Research and development expense                 76 74 77
Restructuring, asset-related, and other charges                 46 56 168
Total other operating expenses                 607 579 1,039
Equity in earnings of affiliates                 0 0 4
Equity in earnings of subsidiaries                 2 0 0
Interest (expense) income, net                 5 3 (3)
(Loss) gain on extinguishment of debt                 0 0 0
Intercompany interest income (expense), net                 10 0 4
Other income (expense), net                 199 139 193
Income (loss) before income taxes                 471 366 (310)
(Benefit from) provision for income taxes                 98 117 (52)
Net income (loss)                 373 249 (258)
Less: Net income attributable to non-controlling interests                 0 0 0
Net income (loss) attributable to Chemours                 373 249 (258)
Comprehensive (loss) income attributable to Chemours                 375 253 (255)
Non-Guarantor Subsidiaries [Member] | Reportable Legal Entities [Member]                      
Condensed Income Statements, Captions [Line Items]                      
Net sales                 4,484 4,030 3,222
Cost of goods sold                 3,380 3,045 2,622
Gross profit                 1,104 985 600
Selling, general, and administrative expense                 163 179 151
Research and development expense                 6 7 4
Restructuring, asset-related, and other charges                 3 1 2
Total other operating expenses                 172 187 157
Equity in earnings of affiliates                 43 33 25
Equity in earnings of subsidiaries                 0 0 0
Interest (expense) income, net                 10 3 1
(Loss) gain on extinguishment of debt                 0 0 0
Intercompany interest income (expense), net                 (57) (64) (64)
Other income (expense), net                 (40) (21) 74
Income (loss) before income taxes                 888 749 479
(Benefit from) provision for income taxes                 111 114 100
Net income (loss)                 777 635 379
Less: Net income attributable to non-controlling interests                 1 1 0
Net income (loss) attributable to Chemours                 776 634 379
Comprehensive (loss) income attributable to Chemours                 $ 637 $ 828 $ 321